After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Nektar Therapeutics is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Nektar Therapeutics is $754.88M. A total of 1.01 million shares were traded on the day, compared to an average of 802.47K shares.
In the most recent transaction, Zalevsky Jonathan sold 3,867 shares of NKTR for 35.67 per share on Jan 20 ’26. After the transaction, the Chief R&D Officer now owns 21,354 company shares. In a previous transaction on Jan 20 ’26, Zalevsky Jonathan bought 3,867 shares at 35.67 per share.
Among the insiders who sold shares, Zalevsky Jonathan disposed of 1,157 shares on Nov 25 ’25 at a per-share price of $54.28. This resulted in the Chief R&D Officer holding 18,971 shares of NKTR after the transaction. In another insider transaction, Wilson Mark Andrew sold 630 shares at $54.28 per share on Nov 25 ’25. Company shares held by the Chief Legal Officer now total 21,585.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, NKTR has a high of $66.92 and a low of $0.43.
As of this writing, NKTR has an earnings estimate of -$2.9 per share for the current quarter. EPS was calculated based on a consensus of 1.0 estimates, with a high estimate of -$2.9 per share and a lower estimate of -$2.9. The company reported an EPS of -$2.25 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. NKTR’s latest balance sheet shows that the firm has $733.96M in Cash & Short Term Investments as of fiscal 2021. There were $143.18M in debt and $85.20M in liabilities at the time. Its Book Value Per Share was $4.33, while its Total Shareholder’s Equity was $679.51M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock.
